Who bills the most Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg (J0702) to Medicare in New York?

81 physician groups billed Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg (J0702) to Medicare fee-for-service in New York in 2024; the top five named groups hold 58% of that volume, and independent (non-hospital-affiliated) groups deliver 3%.

J0702 — Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg · Source: CMS Medicare Physician & Other Practitioners PUF (Part B), CY2024 release. Medicare fee-for-service only.

Snapshot covers the whole New York market — the table below shows the top 100 groups (free tier).

*Share of New York's disclosed Medicare-FFS services for J0702, counted once per clinician. Volume is placed in the state it was billed from, so this page ranks the groups actually billing J0702 in New York — including groups registered elsewhere ("City" is each group's registered location). Group figures sum clinicians affiliated with exactly one group; clinicians in several groups are listed in each group's drill-down but not volume-attributed to any single group.